Organ Donation in Germany – An Analysis (Sponsor: Novartis Pharma GmbH, Nürnberg)
Therapieforum Transplant · 01.12.2020 · 08 (01) · 4-6
DOI: 10.1055/a-1143-1619 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapieforum Transplant, erschienen am 01.12.2020.
Abstract (Originalsprache)
In 2018 the number of organ donors in Germany increased by about 20 % compared with 2017 – from 797 to 955. However, this increase occurred after a long decrease in the rate of organ donation in the years 2010–2017. In that period the number of organ donors per year fell by more than one-third from 1296 donors to 797 [1]. This had dramatic consequences for the prognosis of patients with endstage organ failure: 1500 fewer organ transplantations were performed in 2017 compared with 2010.
Zitieren
APA
(2020). Organ Donation in Germany – An Analysis (Sponsor: Novartis Pharma GmbH, Nürnberg). Therapieforum Transplant, 08(01), 4-6. https://doi.org/10.1055/a-1143-1619
Vancouver
Organ Donation in Germany – An Analysis (Sponsor: Novartis Pharma GmbH, Nürnberg). Therapieforum Transplant. 2020;08(01):4-6. doi:10.1055/a-1143-1619
BibTeX
@article{euvimed2020,
title = {Organ Donation in Germany – An Analysis (Sponsor: Novartis Pharma GmbH, Nürnberg)},
journal = {Therapieforum Transplant},
year = {2020},
volume = {08},
number = {01},
pages = {4--6},
doi = {10.1055/a-1143-1619}
}
EUVIMED